• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Latest News about Biogen Inc

    Recent news which mentions Biogen Inc

    < Previous 1 2 3 Next >
    Biogen tops estimates, raises profit guidance as Alzheimer's drug Leqembi gains traction
    Tags Biotechnology Business US: News
    From CNBC.com News
    Wednesday's big stock stories: What’s likely to move the market in the next trading session
    Tags New York Times Co Amgen Inc Tesla Inc
    From CNBC.com News
    5 things to know before the stock market opens Monday
    Tags Chevron Corp Bristol/Myers Squibb Co Markets
    From CNBC.com News
    Thursday's big stock stories: What's likely to move the market in the next trading session
    Tags Micron Technology Inc Netflix Inc WW Grainger Inc
    From CNBC.com News
    5 things to know before the stock market opens Monday
    Tags General Motors Co Markets Investment strategy
    From CNBC.com News
    Alzheimer's drug Leqembi promises to give patients more time, but they face a long road to treatment
    Tags Eisai Co Ltd Biotech and Pharmaceuticals Business News
    From CNBC.com News
    Biogen beats expectations, hikes outlook as Alzheimer's drug Leqembi and other new products gain traction
    Tags Business News Biotech and Pharmaceuticals Health care industry
    From CNBC.com News
    Patients on Alzheimer's drug Leqembi see benefits over three years, Eisai study says
    Tags Breaking news Pharmaceuticals US: News
    From CNBC.com News
    Older GLP-1 drug from Novo Nordisk may slow Alzheimer's disease progression by protecting the brain, study says
    Tags Health & Science Companies Science
    From CNBC.com News
    European drug regulator rejects Alzheimer's treatment Leqembi from Biogen, Eisai
    Tags Biogen Inc Eli Lilly and Co Companies
    From CNBC.com News
    Jim Cramer says Eli Lilly isn't a 'one trick pony' after FDA advisers endorse its Alzheimer's drug
    Tags Business Investing stocks
    From CNBC.com News
    Cramer's Lightning Round: Bank of America is a buy
    Tags Business Investing Investment Strategy
    From CNBC.com News
    Biogen tops quarterly profit estimates as cost cuts take hold, Leqembi launch picks up
    Tags Health care industry Biotech and Pharmaceuticals Eisai Co Ltd
    From CNBC.com News
    5 things to know before the stock market opens Monday
    Tags Ford Motor Co Snap Inc Tesla Inc
    From CNBC.com News
    Eli Lilly says FDA delays approval of Alzheimer's drug in surprise move
    Tags Eli Lilly and Co Biogen Inc Health & Science
    From CNBC.com News
    Healthy Returns: The launch of breakthrough Alzheimer’s drug Leqembi is off to a slow start
    Tags Health care industry Eisai Co Ltd Biotech and Pharmaceuticals
    From CNBC.com News
    Biogen revenue and profit shrink on Aduhelm costs, slumping sales of multiple sclerosis therapies
    Tags Biogen Inc Earnings Companies
    From CNBC.com News
    5 things to know before the stock market opens Monday
    Tags Anheuser/Busch Inbev SA Investment strategy Coinbase Global Inc
    From CNBC.com News
    Biogen drops controversial Alzheimer's drug Aduhelm to focus on Leqembi, experimental treatments
    Tags Health care industry Business News Biotech and Pharmaceuticals
    From CNBC.com News
    Weight loss drugs, Alzheimer's treatments and gene editing: Enormous firsts defined 2023 in pharma
    Tags Health & Science Companies Biogen Inc
    From CNBC.com News
    5 things to know before the stock market opens Monday
    Tags Walt Disney Co Berkshire Hathaway Inc MGM Resorts International
    From CNBC.com News
    More convenient form of breakthrough Alzheimer's drug Leqembi shows promising results in study
    Tags Health care industry Eisai Co Ltd Biotech and Pharmaceuticals
    From CNBC.com News
    Sage Therapeutics stock plunges 48% after FDA decision on postpartum depression drug
    Tags Depression Pharmaceuticals Breaking news
    From CNBC.com News
    Stocks making the biggest moves premarket: Intel, Roku, Procter & Gamble and more
    Tags First Solar Inc Finance Roku Inc
    From CNBC.com News
    Stocks making the biggest moves midday: Spotify, RTX, General Electric and more
    Tags Finance Market Insider United Parcel Service Inc
    From CNBC.com News
    Biogen to cut 1,000 jobs to save costs as company prepares for Leqembi launch
    Tags Health care industry Biotech and Pharmaceuticals Business News
    From CNBC.com News
    5 things to know before the stock market opens Tuesday
    Tags Technology Business News Eisai Co Ltd
    From CNBC.com News
    Eli Lilly expects FDA decision on Alzheimer's treatment donanemab by the end of the year
    Tags Biogen Inc Eli Lilly and Co Companies
    From CNBC.com News
    Medicare will pay for Alzheimer's drug Leqembi. What patients and doctors should know
    Tags Medicare health plans Policy Alzheimer's disease
    From CNBC.com News
    Sales of Alzheimer’s drug Leqembi may be slow initially but could pick up in 2024
    Tags Pharmaceuticals Alzheimer's disease Regulations
    From CNBC.com News
    < Previous 1 2 3 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.